OnKure Therapeutics, Inc. OKUR Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from OnKure Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about OnKure Therapeutics, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OnKure Therapeutics, Inc.'s current ratio?
- OnKure Therapeutics, Inc. (OKUR) reported current ratio of 13.8× in Q1 2026.
- How has OnKure Therapeutics, Inc.'s current ratio changed year-over-year?
- OnKure Therapeutics, Inc.'s current ratio increased by 23.3% year-over-year, from 11.2× to 13.8×.
- What is the long-term trend for OnKure Therapeutics, Inc.'s current ratio?
- Over 5 years (2020 to 2025), OnKure Therapeutics, Inc.'s current ratio has grown at a -3.1% compound annual growth rate (CAGR), from 12× to 10.3×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.